Lower prevalence of depression in hemodialysis patients who use polysulfone dialyzers

American Journal of Nephrology

Volumn 29, Issue 6, 2009, Pages 592-597

  Hsu, Heng Jung ^a,b   Chen, Chih Ken ^a,b   Wu, Mai Szu ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Depression; Dialyzer; End stage renal disease; Hemodialysis; Polysulfone

Indexed keywords

ALBUMIN; CELLULOSE DERIVATIVE; POLYSULFONE;

ADULT; ARTICLE; ARTIFICIAL KIDNEY; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMERS; PREVALENCE; RENAL DIALYSIS; SULFONES; TAIWAN;

EID: 58149476413     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000193144     Document Type: Article

References (34)

1. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK: Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293-299.
2. Foster FG, Cohn GL, McKegney FP: Psychobiologic factors and individual survival on chronic renal hemodialysis. A two year follow-up. I. Psychosom Med 1973;35:64-82.
3. Kimmel PL, Weihs K, Peterson RA: Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 1993;4:12-27.
4. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH: Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000;57: 2093-2098.
5. Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK: Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002;62:199-207.
6. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA: Clinical depression and inflammatory risk markers for coronary hear t disease. Am J Cardiol 2002;90: 1279-1283.
7. Owen BM, Eccleston D, Ferrier IN, Young AH: Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 2001;103: 226-228.
8. Ferketich AK, Ferguson JP, Binkley PF: Depressive symptoms and inflammation among heart failure patients. Am Heart J 2005;150: 132-136.
9. Loftis JM, Hauser P: The phenomenology and treatment of interferon-induced depression. J Affect Disord 2004;82:175-190.
10. Kalender B, Mutlu B, Ersoz M, Kalkan A, Yilmaz A: The effects of acute phase proteins on serum albumin, transferrin and haemoglobin in haemodialysis patients. Int J Clin Pract 2002;56:505-508.
11. Lowrie EG: Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dialysis patients. Am J Kidney Dis 1998;32:S105-S112.
12. Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, Himmelfarb J: Linkage of hypoalbuminemia, inflamma- tion, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 2003;42:286-294.
13. Memoli B, Postiglione L, Cianciaruso B, Bisesti V, Cimmaruta C, Marzano L, Minutolo R, Cuomo V, Guida B, Andreucci M, Rossi G: Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. Kidney Int 2000;58:417-424.
14. Himmelfarb J, McMenamin E, McMonagle E: Plasma aminothiol oxidation in chronic hemodialysis patients. Kidney Int 2002;61: 705-716.
15. Kalender B, Ozdemir AC, Koroglu G: Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract 2006;102:c115-c121.
16. Chauveau P, Nguyen H, Combe C, Chene G, Azar R, Cano N, Canaud B, Fouque D, Laville M, Leverve X, Roth H, Aparicio M: Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 2005;45:565-571.
17. Walker RJ, Sutherland WH, De Jong SA: Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers. Clin Nephrol 2004;61: 198-206.
18. Hakim RM, Breillatt J, Lazarus JM, Port FK: Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984;311:878-882.
19. Olsson I, Mykletun A, Dahl AA: The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005;5:46.
20. Tweed AE, Metcalfe M, Taylor R: Mood and quality of life in kidney transplant patients: is there an inf luence of organ source? Proc Br Psychol Soc Annu Conf 2002;10:104.
21. Martin CR, Thompson DR: The Hospital Anxiety and Depression Scale in patients undergoing peritoneal dialysis: internal and test re-test reliability. Clin Effect Nurs 2002;6: 77-79.
22. I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000. Am J Kidney Dis 2001;37:S7-S64.
23. Dantzer R: Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 20 01;15: 7- 2 4 .
24. Panagiotakos DB, Pitsavos C, Chrysohoou C, Tsetsekou E, Papageorgiou C, Christo- doulou G, Stefanadis C: Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people;the ATTICA study. Eur Heart J 2004;25:492-499.
25. Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine MD, Haeffner-Cavaillon N: Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Int 1990;38:1089-1094.
26. Chanard J, Lavaud S, Randoux C, Rieu P: New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin binding. Nephrol Dial Transplant 2003;18:252-257.
27. Bommer J, Seelig P, Seelig R, Geerlings W, Bommer G, Ritz E: Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility. Nephrol Dial Transplant 1987;2:22-25.
28. Zingraff J, Beyne P, Urena P, Uzan M, Nguyen Khoa M, Descamps-Latscha B, Drueke T: Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies. Nephrol Dial Transplant 1988;3:284-290.
29. Ronco C, Ballestri M, Cappelli G: Dialysis membranes in convective treatments. Nephrol Dial Transplant 2000;15(suppl 2):31-36.
30. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, Orlandini G: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 19 96;50: 1293-1302.
31. Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F: Carpal tunnel syndrome and type of dialysis membrane. BMJ 1989;298: 867-868.
32. van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J: Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int 1991;39:1012-1019.
33. Robinson RG: Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003;54:376-387.
34. Reiche EM, Nunes SO, Morimoto HK: Stress, depression, the immune system, and cancer. Lancet Oncol 20 04;5:617-625.